Cargando…

Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection

BACKGROUND: Statins may be protective in viral infection and have been proposed as treatment in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. OBJECTIVE: We evaluated the effect of statins on mortality in four groups hospitalized with (SARS-CoV-2) infection (continued statin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Memel, Zoe N., Lee, Jenny J., Foulkes, Andrea S., Chung, Raymond T., Thaweethai, Tanayott, Bloom, Patricia P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043489/ https://www.ncbi.nlm.nih.gov/pubmed/33851192 http://dx.doi.org/10.1101/2021.03.27.21254373

Ejemplares similares

Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Memel, Zoe N, et al.
Publicado: (2021)

Body composition predictors of outcome in patients with COVID-19
por: Bunnell, Katherine M., et al.
Publicado: (2021)

Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021
por: Ciuffreda, Laura, et al.
Publicado: (2022)

Response to Letter to the Editor From Nelson et al: “Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response”
por: Foulkes, Andrea S, et al.
Publicado: (2022)

Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant
por: Müller, Veronika, et al.
Publicado: (2022)

Signature biomarker states and mortality among hospitalized SARS-CoV-2-infected patients
por: Selvaggi, Caitlin, et al.
Publicado: (2022)

Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
por: Crooks, Colin, et al.
Publicado: (2011)

Impact of early hyperoxia on 28-day in-hospital mortality in patients with myocardial injury
por: Kim, Tae Yun, et al.
Publicado: (2018)

Genetically Determined Variation in Lysis Time Variance in the Bacteriophage φX174
por: Baker, Christopher W., et al.
Publicado: (2016)

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2005)

Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19
por: Yetmar, Zachary A., et al.
Publicado: (2021)

Looking beyond 28-day all-cause mortality
por: Rubenfeld, Gordon
Publicado: (2002)

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
por: Hoertel, Nicolas, et al.
Publicado: (2023)

STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION
por: Siddiqi, Hasan, et al.
Publicado: (2021)

Functional principal component analysis and sparse-group LASSO to identify associations between biomarker trajectories and mortality among hospitalized SARS-CoV-2 infected individuals
por: Cao, Tingyi, et al.
Publicado: (2023)

Factors Associated within 28 Days In-Hospital Mortality of Patients with Acute Respiratory Distress Syndrome
por: Sharif, Nadia, et al.
Publicado: (2013)

Association Analysis of Hyperlipidemia with the 28-Day All-Cause Mortality of COVID-19 in Hospitalized Patients
por: Wu, Bin, et al.
Publicado: (2021)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, N., et al.
Publicado: (2023)

Activated protein C, severe sepsis and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2012)

Trauma Early Mortality Prediction Tool (TEMPT) for assessing 28-day mortality
por: Kunitake, Ryan C, et al.
Publicado: (2018)

Presence of SARS-CoV-2 RNA in isolation ward environment 28 days after exposure
por: Zhou, Yunyun, et al.
Publicado: (2020)

Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
por: Tagami, Takashi, et al.
Publicado: (2017)

Association of Statins With Functional Outcome and 30-Day Mortality in Patients With Intracerebral Hemorrhage
por: Silva Marques, Joana, et al.
Publicado: (2021)

Fentanyl- and midazolam-induced coma each influence days of mechanical ventilation and 28-day mortality
por: Tanios, Maged, et al.
Publicado: (2021)

Single pro-adrenomedullin determination in septic shock and 28-day mortality
por: Garcia-de la Torre, A, et al.
Publicado: (2014)

The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19
por: Fathi, M., et al.
Publicado: (2022)

SARS-CoV-2 infection in infants aged 28 days and younger. A multicentre case series()
por: Velasco Rodríguez-Belvís, Marta, et al.
Publicado: (2022)

Association of hyperglycaemia at-admission & diabetes mellitus with 28 day mortality in patients admitted with moderate-severe SARS-CoV-2 infection: A retrospective study
por: Kurian, Navya Mary, et al.
Publicado: (2022)

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study
por: Paiva, José-Artur, et al.
Publicado: (2016)

Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019: An International Cohort Study
por: Li Bassi, Gianluigi, et al.
Publicado: (2021)

Antipsychotic use and 28-day Mortality in Patients Hospitalized with COVID-19: a multicenter observational retrospective study
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

MR-proADM has a good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: Honore, Patrick M., et al.
Publicado: (2022)

A cohort study of routinely used sepsis biomarkers and 28-day mortality
por: De La Torre-Prados, M, et al.
Publicado: (2013)

Effect of hydrocortisone on the 28-day mortality of patients with septic acute kidney injury
por: Ying, Pan, et al.
Publicado: (2019)

Predictors of mortality at 28-days in infection associated acute kidney injury in cirrhosis
por: Gupta, Tarana, et al.
Publicado: (2022)

An immune-related gene signature predicts the 28-day mortality in patients with sepsis
por: Peng, Yaojun, et al.
Publicado: (2023)

Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
por: Rong, Yiran, et al.
Publicado: (2023)

Clinical characteristics and 28-day mortality of medical patients admitted with COVID-19 to a central London teaching hospital
por: Khalil, K., et al.
Publicado: (2020)

Sentiment Analysis Based on the Nursing Notes on In-Hospital 28-Day Mortality of Sepsis Patients Utilizing the MIMIC-III Database
por: Gao, Qiaoyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3t8lb6991t0rjncd9bac2fjesk